Kaposi sarcoma-associated herpesvirus: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

curprev 09:3909:39, 26 October 2023‎ Aidan talk contribs‎ m 1,768 bytes +4‎ →�

curprev 07:4207:42, 11 November 2022‎ Aidan talk contribs‎ m 1,764 bytes 0‎ Aidan moved page Kaposi sarcoma–associated herpesvirus to Kaposi sarcoma-associated herpesvirus without leaving a redirect

curprev 08:5808:58, 2 October 2022‎ Aidan talk contribs‎ 1,764 bytes +140‎ No edit summary Tag: Visual edit
curprev 08:5608:56, 2 October 2022‎ Aidan talk contribs‎ m 1,624 bytes 0‎ Aidan moved page Human herpesvirus 8 to Kaposi sarcoma–associated herpesvirus
curprev 08:5508:55, 2 October 2022‎ Aidan talk contribs‎ 1,624 bytes +262‎ No edit summary Tag: Visual edit
curprev 08:2108:21, 2 October 2022‎ Aidan talk contribs‎ 1,362 bytes +591‎ No edit summary Tag: Visual edit

curprev 14:1414:14, 1 October 2022‎ Aidan talk contribs‎ 771 bytes +382‎ added a few other clinical manifestations

curprev 13:5713:57, 1 October 2022‎ Aidan talk contribs‎ 389 bytes +389‎ Created page with "== Background == * Seroprevalence variés by geography and group ** US general population 1-5% ** US men who have sex with men 15-20% ** US MSM with HIV 30-35% ** Some Mediterranean countries 10-20% ** Sub-Saharan African countries 30-80% == Clinical Manifestations == * Mostly asymptomatic * Kaposi sarcoma == Management == * See Kaposi sarcoma Category:Human herpesviruses"

Kaposi sarcoma-associated herpesvirus: Revision history

26 October 2023

11 November 2022

2 October 2022

1 October 2022